Atea Pharmaceuticals (AVIR) Current Taxes (2021 - 2023)

Atea Pharmaceuticals' Current Taxes history runs 3 years deep, the most recent figure standing at $23000.0 for Q2 2023.

• In Q2 2023, Current Taxes rose 53.33% year-over-year to $23000.0; the TTM figure through Jun 2023 stood at $23000.0 (up 53.33% YoY), while the FY2022 annual figure was $99000.0, down 96.15% from the prior year.
• Current Taxes for Q2 2023 stood at $23000.0, down from $178000.0 in the prior quarter.
• The five-year high for Current Taxes was $12.0 million in Q3 2021, with the low at $15000.0 in Q2 2022.
• The 3-year median for Current Taxes is $708000.0 (2022), against an average of $2.8 million.
• The sharpest annual moves came in 2022 and 2023: Current Taxes plunged 99.79% in 2022, then soared 53.33% in 2023.
• Atea Pharmaceuticals' Current Taxes stood at $2.6 million in 2021, then tumbled by 96.15% to $99000.0 in 2022, then plunged by 76.77% to $23000.0 in 2023.
• Business Quant data shows AVIR's Current Taxes at $23000.0 in Q2 2023, $178000.0 in Q1 2023, and $99000.0 in Q4 2022.